Testing effectiveness (Phase 2)Looking for participantsNCT05588141
What this trial is testing
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Who this might be right for
Brain TumorCancer
National Cancer Institute (NCI) 96